A031702-Phase II Study of Cabozantinib in Combination with Nivolumab and Ipilimumab in Rare Genitourinary Tumors

January 05, 2020
https://clinicaltrials.gov/ct2/show/NCT03866382
Cancer - Bladder, Cancer - Prostate, Cancer - Rare
Principal Investigator: Ding Wang, MD

Bladder Adenocarcinoma,  Bladder Mixed Adenocarcinoma, Bladder Small Cell Carcinoma,  Chromophobe Renal Cell Carcinoma, Large Cell Neuroendocrine Carcinoma, Testicular Leydig Cell Tumor, Testicular Sertoli Cell Tumor, Stage IV Penile Cancer, Stage IV Prostate Cancer, Stage IV Renal Cell Cancer, Stage IVB Bladder Cancer, Stage IVA Bladder Cancer, Stage IV Bladder Cancer, Papillary Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma,  Metastatic Kidney Medullary Carcinoma, Metastatic Malignant Genitourinary System Neoplasm

 

Accepting Participants